Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 6.0B | 4.3B | 4.5B | 4.7B |
Cost of revenue | — | — | 2.5B | 2.4B |
Gross profit | — | — | 1.9B | 2.2B |
Operating expense | ||||
Research & development | 1.1B | 1.1B | 1.1B | 1.1B |
Selling general and admin | 789M | 692M | 715M | 708M |
Other operating expenses | — | — | -345M | -7M |
Operating income | 490M | 246M | 432M | 399M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | 3M | 1M |
Pretax income | 1.1B | 145M | 461M | 451M |
Tax provision | — | — | 92M | 12M |
Net income | 813M | 175M | -142M | 439M |
Basic EPS | — | 0.0 | 0.0 | 0.1 |
Diluted EPS | — | 0.0 | 0.0 | 0.1 |
Basic average shares | — | 5.5B | 5.5B | 5.5B |
Diluted average shares | — | 5.8B | 5.6B | 5.6B |
EBITDA | 1.3B | 246M | 700M | 660M |
Net income from continuing op. | — | — | -142M | 438M |
Minority interests | — | — | -3M | -4M |
Preferred stock dividends | — | — | — | — |